Acclaro Medical's UltraClear Laser Approved in Canada
Acclaro Medical, a leading innovator in energy-based technology for aesthetic and surgical markets, has recently achieved a remarkable milestone. The company announced that its groundbreaking UltraClear® 2910 nm cold ablative fiber laser has received approval from Health Canada. This innovative device promises to elevate the standard for skin rejuvenation treatments across the nation.
What is UltraClear?
The UltraClear fiber laser is engineered with proprietary technologies, including the MID IR Fiber Laser and the 3DIntelliPulse™ technology. This pioneering system is recognized as the world’s first 2910 nm cold ablative laser, designed to provide precise and customizable treatments aimed at addressing various skin issues from superficial to deeper concerns while ensuring minimal downtime and exceptional comfort for patients.
In addition to its approval, Acclaro has partnered with Xcite Technology, a notable leader in the field of energy-based aesthetic devices, to facilitate the commercialization and distribution of UltraClear in Canada. This strategic alliance aims to ensure that clinics and patients nationwide have access to one of the most advanced skin rejuvenation platforms available today.
A New Era in Skin Rejuvenation
The approval of UltraClear represents a significant advancement in treatment options for Canadian providers and patients alike. Helen Fang, CEO of Acclaro Medical, expressed her excitement about this launch, stating, "The approval of our UltraClear in Canada as the first and only 2910 nm fiber laser marks a significant milestone in our steadfast commitment to bringing breakthrough innovation to Canadian aesthetic providers and their patients."
Bill Roberts, CEO of Xcite Technologies, echoed this sentiment, highlighting how UltraClear is unique compared to other devices on the market. He remarked, "The 2910 nm cold ablative fiber laser combined with proprietary Laser Coring technology delivers a level of precision and depth that truly redefines skin rejuvenation."
Key Features of UltraClear
The UltraClear laser includes unique treatment modes designed to cater to the diverse needs of patients:
- - 3DMIRACL®: This mode is suitable for gentle resurfacing treatments, ideal for restoring skin texture.
- - Laser Coring™: A first-of-its-kind technology that aids in addressing noticeable signs of aging and gravity effects on the skin, making it a more complex solution than standard treatments.
With these advanced features, practitioners can offer a range of treatment options tailored to the individual needs and skin types of their clients, thereby enhancing patient satisfaction and outcomes.
Committed to Innovation
Since its founding in 2018 by a team of industry experts, Acclaro Medical has dedicated itself to developing and delivering innovative solutions to meet the evolving needs of aesthetic and surgical practices. Their products are designed to provide high patient comfort, rapid healing, and superior safety across all skin types.
The introduction of UltraClear is not just about expanding their product line but also about helping aesthetic clinics improve their treatment standards and offerings significantly. Acclaro’s ongoing mission focuses on redefining patient experience and results in the field of aesthetic medicine.
Future Plans
As the exclusive distributor of UltraClear in Canada, Xcite Technologies is strategically positioned to support clinical adoption and market penetration, invigorating the aesthetic treatment landscape. Through this collaboration, both companies hope to continue addressing unmet needs in the medical and aesthetic fields, making high-efficacy treatments accessible to a broader audience.
For further information on UltraClear and its availability in Canada, please visit Acclaro Medical’s official website or contact Xcite Technologies directly.